Logo-bi
Bioimpacts. 2013;3(4): 201-202. doi: 10.5681/bi.2013.034
PMID: 24455485        PMCID: PMC3892741

Commentary

Authors’ reply: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Gerardo Alvarez-Uria 1 * , Manoranjan Midde 1, Raghavakalyan Pakam 1, Praveen Kumar Naik 1

Cited by CrossRef: 0




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge